11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders? Επικοινωνία Submitted by Δημήτρης Σπάχος on Δευ, 05/04/2015 - 10:41
